Acuzar, Edrazil .

HRN: 22-32-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2023
CEFUROXIME 1.5GM (VIAL)
02/20/2023
02/20/2023
IV
1.5GM
Prior OR
Prophylaxis For OR
Waiting Final Action 
02/20/2023
CEFUROXIME 1.5GM (VIAL)
02/20/2023
02/20/2023
IV
1.5gm
Q8 X 2 More Doses
Post OP (Cesarean Section) Prophylaxis
Waiting Final Action 
02/21/2023
CEFUROXIME 500MG (TAB)
02/21/2023
02/28/2023
ORAL
500mg
Q12
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: